Compare $OLMA vs $PRME | Chartloom

Compare

$OLMA vs $PRME

Olema Pharmaceuticals Inc · Prime Medicine Inc

OLMA

Olema Pharmaceuticals Inc

PRME

Prime Medicine Inc

Compare $OLMA vs $PRME

Comparing Olema Pharmaceuticals Inc and Prime Medicine Inc

OLMAOlema Pharmaceuticals Inc

PRMEPrime Medicine Inc

OLMAOlema Pharmaceuticals Inc

Market cap

$683M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-27.1%

FCF yield

-24.1%

PRMEPrime Medicine Inc

Market cap

$721M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

126.79x

Rev growth (TTM)

-17.9%

YTD performance

13.0%

52W performance

-38.1%

FCF yield

-21.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OLMA

PRME

Detailed metrics comparison

OLMA

Olema Pharmaceuticals Inc

PRME

Prime Medicine Inc

Market Cap

OLMA$683M

PRME$721M

Enterprise Value

OLMA$637M

PRME$673M

Price

OLMA$7.82

PRME$3.99

P/E Ratio

OLMAN/A

PRMEN/A

P/S Ratio

OLMA0.00x

PRME176.94x

EV/Sales

OLMA0.00x

PRME165.29x

EV/EBITDA

OLMA0.00x

PRME0.00x

P/B Ratio

OLMA1.67x

PRME13.58x

P/FCF Ratio

OLMAN/A

PRMEN/A

EV/FCF

OLMA-3.86x

PRME-4.29x

PEG Ratio

OLMAN/A

PRMEN/A

Forward P/E (NTM)

OLMAN/A

PRMEN/A

Forward P/S (NTM)

OLMAN/A

PRME126.79x

Revenue (TTM)

OLMA$0

PRME$4M

Revenue Growth (YoY)

OLMAN/A

PRME-17.9%

Forward Rev Growth

OLMA820.6%

PRME22.7%

Gross Margin (TTM)

OLMA0.0%

PRME0.0%

Operating Margin (TTM)

OLMA0.0%

PRME0.0%

EBITDA Margin (TTM)

OLMA0.0%

PRME-4643.3%

Net Margin (TTM)

OLMA0.0%

PRME-4613.1%

FCF Margin (TTM)

OLMAN/A

PRME-3850.9%

Net Income (TTM)

OLMA$-205M

PRME$-188M

FCF (TTM)

OLMA$-165M

PRME$-157M

EPS (TTM)

OLMA-$1.96

PRME-$1.06

ROE (TTM)

OLMA-4822.0%

PRME-18827.0%

ROA (TTM)

OLMA-4300.0%

PRME-5911.0%

ROIC (TTM)

OLMA-4788.0%

PRME-18827.0%

Cash

OLMA$49M

PRME$47M

Debt

OLMA$3M

PRME$0

Net Cash/Debt

OLMA$46M

PRME$47M

Current Ratio (TTM)

OLMA8.86x

PRME3.05x

Quick Ratio (TTM)

OLMA8.75x

PRME3.01x

Debt/Equity (TTM)

OLMA0.01x

PRME0.00x

Debt/Assets (TTM)

OLMA0.0%

PRME0.0%

Interest Coverage (TTM)

OLMAN/A

PRMEN/A

Net Debt/EBITDA (TTM)

OLMA0.00x

PRME0.00x

Beta

OLMA1.98

PRME2.35

52W Performance

OLMA-27.1%

PRME-38.1%

YTD Performance

OLMA-69.1%

PRME13.0%

% from 52W High

OLMA-78.4%

PRME-40.0%

% from 52W Low

OLMA17.6%

PRME49.4%

Asset Turnover (TTM)

OLMA0.00x

PRME0.01x

FCF Yield (TTM)

OLMA-24.1%

PRME-21.8%

Earnings Yield (TTM)

OLMA-29.9%

PRME-26.1%

Dividend Yield (TTM)

OLMAN/A

PRMEN/A

Rule of 40

OLMA0.0

PRME-3,868.8

EV/GP/RG

OLMAN/A

PRMEN/A

Ticker research

View OLMA research View PRME research

Metric	OLMA Olema Pharmaceuticals Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$683M	$721M
Enterprise Value	$637M	$673M
Price	$7.82	$3.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	176.94x
EV/Sales	0.00x	165.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.67x	13.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.86x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	126.79x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-17.9%
Forward Rev Growth	820.6%	22.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4643.3%
Net Margin (TTM)	0.0%	-4613.1%
FCF Margin (TTM)	N/A	-3850.9%
Net Income (TTM)	$-205M	$-188M
FCF (TTM)	$-165M	$-157M
EPS (TTM)	-$1.96	-$1.06
ROE (TTM)	-4822.0%	-18827.0%
ROA (TTM)	-4300.0%	-5911.0%
ROIC (TTM)	-4788.0%	-18827.0%
Financial Health
Cash	$49M	$47M
Debt	$3M	$0
Net Cash/Debt	$46M	$47M
Current Ratio (TTM)	8.86x	3.05x
Quick Ratio (TTM)	8.75x	3.01x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.98	2.35
52W Performance	-27.1%	-38.1%
YTD Performance	-69.1%	13.0%
% from 52W High	-78.4%	-40.0%
% from 52W Low	17.6%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-24.1%	-21.8%
Earnings Yield (TTM)	-29.9%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,868.8
EV/GP/RG	N/A	N/A
Ticker research	View OLMA research	View PRME research

Valuation

P/S Ratio

OLMA

0.00x

PRME

176.94x

EV/FCF

PRME

-4.29x

OLMA

-3.86x

Growth & revenue

Revenue Growth TTM

PRME

-17.9%

Forward Revenue Growth

OLMA

820.6%

PRME

22.7%

Profitability & performance

Gross Margin

OLMA

0.0%

PRME

0.0%

ROE

OLMA

-4822.0%

PRME

-18827.0%

FCF Yield %

PRME

-21.8%

OLMA

-24.1%

52-Week Performance

OLMA

-27.1%

PRME

-38.1%

Detailed metrics comparison

OLMA

Olema Pharmaceuticals Inc

PRME

Prime Medicine Inc

Market Cap

OLMA$683M

PRME$721M

Enterprise Value

OLMA$637M

PRME$673M

Price

OLMA$7.82

PRME$3.99

P/E Ratio

OLMAN/A

PRMEN/A

P/S Ratio

OLMA0.00x

PRME176.94x

EV/Sales

OLMA0.00x

PRME165.29x

EV/EBITDA

OLMA0.00x

PRME0.00x

P/B Ratio

OLMA1.67x

PRME13.58x

P/FCF Ratio

OLMAN/A

PRMEN/A

EV/FCF

OLMA-3.86x

PRME-4.29x

PEG Ratio

OLMAN/A

PRMEN/A

Forward P/E (NTM)

OLMAN/A

PRMEN/A

Forward P/S (NTM)

OLMAN/A

PRME126.79x

Revenue (TTM)

OLMA$0

PRME$4M

Revenue Growth (YoY)

OLMAN/A

PRME-17.9%

Forward Rev Growth

OLMA820.6%

PRME22.7%

Gross Margin (TTM)

OLMA0.0%

PRME0.0%

Operating Margin (TTM)

OLMA0.0%

PRME0.0%

EBITDA Margin (TTM)

OLMA0.0%

PRME-4643.3%

Net Margin (TTM)

OLMA0.0%

PRME-4613.1%

FCF Margin (TTM)

OLMAN/A

PRME-3850.9%

Net Income (TTM)

OLMA$-205M

PRME$-188M

FCF (TTM)

OLMA$-165M

PRME$-157M

EPS (TTM)

OLMA-$1.96

PRME-$1.06

ROE (TTM)

OLMA-4822.0%

PRME-18827.0%

ROA (TTM)

OLMA-4300.0%

PRME-5911.0%

ROIC (TTM)

OLMA-4788.0%

PRME-18827.0%

Cash

OLMA$49M

PRME$47M

Debt

OLMA$3M

PRME$0

Net Cash/Debt

OLMA$46M

PRME$47M

Current Ratio (TTM)

OLMA8.86x

PRME3.05x

Quick Ratio (TTM)

OLMA8.75x

PRME3.01x

Debt/Equity (TTM)

OLMA0.01x

PRME0.00x

Debt/Assets (TTM)

OLMA0.0%

PRME0.0%

Interest Coverage (TTM)

OLMAN/A

PRMEN/A

Net Debt/EBITDA (TTM)

OLMA0.00x

PRME0.00x

Beta

OLMA1.98

PRME2.35

52W Performance

OLMA-27.1%

PRME-38.1%

YTD Performance

OLMA-69.1%

PRME13.0%

% from 52W High

OLMA-78.4%

PRME-40.0%

% from 52W Low

OLMA17.6%

PRME49.4%

Asset Turnover (TTM)

OLMA0.00x

PRME0.01x

FCF Yield (TTM)

OLMA-24.1%

PRME-21.8%

Earnings Yield (TTM)

OLMA-29.9%

PRME-26.1%

Dividend Yield (TTM)

OLMAN/A

PRMEN/A

Rule of 40

OLMA0.0

PRME-3,868.8

EV/GP/RG

OLMAN/A

PRMEN/A

Ticker research

View OLMA research View PRME research

Metric	OLMA Olema Pharmaceuticals Inc	PRME Prime Medicine Inc
Market & Valuation
Market Cap	$683M	$721M
Enterprise Value	$637M	$673M
Price	$7.82	$3.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	176.94x
EV/Sales	0.00x	165.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.67x	13.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.86x	-4.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	126.79x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	-17.9%
Forward Rev Growth	820.6%	22.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4643.3%
Net Margin (TTM)	0.0%	-4613.1%
FCF Margin (TTM)	N/A	-3850.9%
Net Income (TTM)	$-205M	$-188M
FCF (TTM)	$-165M	$-157M
EPS (TTM)	-$1.96	-$1.06
ROE (TTM)	-4822.0%	-18827.0%
ROA (TTM)	-4300.0%	-5911.0%
ROIC (TTM)	-4788.0%	-18827.0%
Financial Health
Cash	$49M	$47M
Debt	$3M	$0
Net Cash/Debt	$46M	$47M
Current Ratio (TTM)	8.86x	3.05x
Quick Ratio (TTM)	8.75x	3.01x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.98	2.35
52W Performance	-27.1%	-38.1%
YTD Performance	-69.1%	13.0%
% from 52W High	-78.4%	-40.0%
% from 52W Low	17.6%	49.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-24.1%	-21.8%
Earnings Yield (TTM)	-29.9%	-26.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,868.8
EV/GP/RG	N/A	N/A
Ticker research	View OLMA research	View PRME research